First Light Asset Management’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,278,670
Closed -$2.99M 86
2023
Q3
$2.99M Buy
2,278,670
+52,930
+2% +$77.2K 0.28% 42
2023
Q2
$3.9M Sell
2,225,740
-8,916
-0.4% -$11.8K 0.31% 44
2023
Q1
$3.75M Buy
2,234,656
+1,700,000
+318% +$4.42M 0.34% 41
2022
Q4
$1.6M Buy
534,656
+18,649
+4% +$73.2K 0.15% 43
2022
Q3
$2.26M Hold
516,007
0.23% 44
2022
Q2
$2.06M Buy
516,007
+3,700
+0.7% +$14.2K 0.24% 45
2022
Q1
$2.03M Buy
512,307
+24,215
+5% +$90.2K 0.18% 49
2021
Q4
$2.29M Buy
488,092
+13,092
+3% +$93K 0.16% 53
2021
Q3
$3.31M Hold
475,000
0.22% 51
2021
Q2
$5.53M Buy
+475,000
New +$6.12M 0.33% 46

First Light Asset Management's MIRO Position: Q4 2023 in Review

First Light Asset Management sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q4 2023, closing a stake of 2,278,670 shares — an estimated $2.99M sold.

First Light Asset Management first reported a position in MIRO in Q2 2021 and held it in 10 quarters. The position peaked at $5.53M in Q2 2021. 0 funds tracked by Wall St. Rank hold MIRO as of Q4 2023.

  • First Light Asset Management reported no remaining Miromatrix Medical Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • First Light Asset Management sold 2,278,670 Miromatrix Medical Inc. Common Stock shares in Q4 2023, an estimated $2.99M.
  • First Light Asset Management first reported a position in Miromatrix Medical Inc. Common Stock in Q2 2021 and held it in 10 quarters.
  • First Light Asset Management's Miromatrix Medical Inc. Common Stock position peaked at $5.53M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q4 2023.

Based on First Light Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.